Federation des caisses Desjardins du Quebec’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-330
Closed -$5.48K 2171
2018
Q3
$5.48K Hold
330
﹤0.01% 1861
2018
Q2
$5.3K Buy
+330
New +$5.3K ﹤0.01% 1887